Benign Prostatic Hyperplasia Implants Market

Published May 2022 | 9 Pages | 5 Exhibits | Forecasts Through 2026

snapshot
snapshot

Order individually or subscribe and get a complete intel platform.

Overview

This report from Life Science Intelligence provides an analysis of the global market for implants for the treatment of symptomatic benign prostatic hyperplasia (BPH). Implants are a temporary or permanent solution for men suffering from symptoms caused by prostate enlargement. LSI projects that this market will thrive throughout the forecast period as these devices become more accessible to men seeking relief from BPH. 

This market snapshot is intended to provide a high-level overview of the global BPH implants market, with key insights into:

  • Unit volumes from 2020 to 2026
  • Market forecasts from 2020 to 2026
  • Competitive landscape analysis of major competitors
  • Insights into key market events for strategics and startups

Companies Covered

BD

Boston Scientific

Endotherapeutics

Fabian

Olympus

ProArc

ProVerum

Teleflex

ZenFlow

Accelerate your business

We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.